Articles by Eric S. Langer - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Eric S. Langer

Eric S. Langer


President and Managing Partner at BioPlan Associates, Inc. He is also the editor of Advances in Biopharmaceutical Technology in India.

Articles
Bioprocessing Advances in Vaccine Manufacture
August 1, 2013

Advances in techniques and single-use systems are revolutionizing vaccine manufacturing.

What Happened to Outsourcing in Asia?
July 1, 2013

The industry may not be ready for India and China as regulatory issues emerge.

Outsourcing's Modest Role as a Cost-Containment Strategy
May 1, 2013

Outsourcing is weighing in more as a tactic for cost-cutting, but it is still not the primary weapon.

Ten Years Later: Innovation Driving Single-Use Technology Advances
April 2, 2013

BioPlan's Annual Report shows continued growth in the use of single-use technology.

Emerging Outsourcing Trends in 2013
March 2, 2013

BioPlan's outsourcing survey gives insight on top activities, budgets, and growth trends in biopharmaceutical outsourcing.

Outsourcing Nontraditional Protein Expression Systems
March 1, 2013

Growth is seen in outsourcing of insect- and plant-cell-based bioproduction expression systems.

Offshoring Biomanufacturing
January 1, 2013

Will international biomanufacturing outsourcing become mainstream in this decade?

The Future of Biopharma
January 1, 2013

What the industry's future holds and what needs to be done to get there.

Gauging Biopharm Outsourcing
August 1, 2012

Budgets for biopharma activities are gaining in select functional areas, except outsourcing.

ADVERTISEMENT

ADVERTISEMENT

Click here